Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.15 HKD | -0.28% | -2.32% | -34.88% |
Apr. 30 | Cutia Therapeutics' Unit Receives Jiangsu Drug Manufacturing Certificate | MT |
Apr. 30 | Cutia Therapeutics Submits NDA for Androgenetic Alopecia Treatment Spray; Shares Jump 6% | MT |
Sales 2023 | 138M 19.05M 149M | Sales 2024 * | 282M 38.99M 305M | Capitalization | 2.01B 279M 2.18B |
---|---|---|---|---|---|
Net income 2023 | -1.96B -272M -2.13B | Net income 2024 * | -486M -67.28M -526M | EV / Sales 2023 | 22 x |
Net cash position 2023 * | 315M 43.6M 341M | Net Debt 2024 * | 223M 30.87M 241M | EV / Sales 2024 * | 7.94 x |
P/E ratio 2023 |
-1.04
x | P/E ratio 2024 * |
-4.14
x | Employees | 298 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 79.63% |
1 day | -0.28% | ||
1 week | -2.32% | ||
Current month | -2.32% | ||
1 month | +0.70% | ||
3 months | +15.32% | ||
6 months | -66.19% | ||
Current year | -34.88% |
Managers | Title | Age | Since |
---|---|---|---|
Le Le Zhang
FOU | Founder | 46 | 19-05-14 |
Yu Qing Huang
DFI | Director of Finance/CFO | 34 | 21-05-09 |
Lei Lei
CTO | Chief Tech/Sci/R&D Officer | 40 | 20-01-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tak Yan Tao
BRD | Director/Board Member | 48 | 23-05-31 |
Lian Yong Chen
CHM | Chairman | 62 | 19-08-22 |
Ming Kit Chung
BRD | Director/Board Member | 46 | 23-06-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 7.15 | -0.28% | 249,800 |
24-05-07 | 7.17 | -0.97% | 276,000 |
24-05-06 | 7.24 | -4.99% | 565,000 |
24-05-03 | 7.62 | +2.70% | 158,400 |
24-05-02 | 7.42 | +1.37% | 47,200 |
Delayed Quote Hong Kong S.E., May 08, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.88% | 279M | |
+32.95% | 700B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B | |
-1.81% | 157B |
- Stock Market
- Equities
- 2487 Stock